 serum tumor markers patients testicular cancer induction chemotherapy due reservoir markers cystic differentiated mature teratoma serum tumor markers patients testicular cancer induction chemotherapy instances presence residual malignant disease patients elevated tumor markers chemotherapy retroperitoneal lymph node dissection residual malignant disease cystic differentiated mature teratoma high content alpha-fetoprotein beta-human chorionic gonadotropin cysts leakage contents cysts plasma compartment responsible serum tumor marker levels Recognition entities consequence unnecessary salvage chemotherapy patients